Sterling Capital Management’s Avalyn Pharma AVLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.3K Buy
501
+352
+236% +$11.4K ﹤0.01% 2355
2026
Q2
$4.9K Buy
+149
New +$4.3K ﹤0.01% 2625

Other funds holding AVLN

Sterling Capital Management's AVLN Position: Q3 2026 in Review

Sterling Capital Management increased its Avalyn Pharma (AVLN) stake by 236% in Q3 2026, buying an estimated $11.4K and bringing the position to 501 shares worth $14.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2355.

Sterling Capital Management first reported a position in AVLN in Q2 2026 and has held it in 2 quarters since. 116 funds tracked by Wall St. Rank hold AVLN as of Q3 2026.

  • Sterling Capital Management held 501 shares of Avalyn Pharma worth $14.3K as of Q3 2026.
  • Sterling Capital Management bought 352 Avalyn Pharma shares in Q3 2026, an estimated $11.4K.
  • Avalyn Pharma made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2355 holding.
  • Sterling Capital Management first reported a position in Avalyn Pharma in Q2 2026 and has held it in 2 quarters since.
  • 116 funds tracked by Wall St. Rank held Avalyn Pharma as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.